Hoth Therapeutics Files 8-K: Other Events
Ticker: HOTH · Form: 8-K · Filed: May 2, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 8-K |
| Filed Date | May 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: other-events, sec-filing
Related Tickers: HOTH
TL;DR
HOTH filed an 8-K for 'Other Events' on May 2nd. Details TBD.
AI Summary
On May 2, 2025, Hoth Therapeutics, Inc. filed an 8-K report to disclose other events. The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates that Hoth Therapeutics has reported an event requiring immediate disclosure to the SEC, though the specifics are not yet detailed in this initial report.
Risk Assessment
Risk Level: medium — The filing is for 'Other Events' without immediate specific details, which can introduce uncertainty for investors.
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- May 2, 2025 (date) — Filing Date
FAQ
What specific event(s) are being reported under 'Other Events'?
The provided filing excerpt does not specify the nature of the 'Other Events' being reported by Hoth Therapeutics, Inc.
When was this 8-K filing submitted?
The 8-K filing was submitted on May 2, 2025.
What is Hoth Therapeutics, Inc.'s principal executive office address?
Hoth Therapeutics, Inc.'s principal executive offices are located at 1177 Avenue of the Americas, 5th Floor, Suite 5066, New York, NY 10036.
What is Hoth Therapeutics, Inc.'s telephone number?
Hoth Therapeutics, Inc.'s telephone number is (646) 756-2997.
In which state is Hoth Therapeutics, Inc. incorporated?
Hoth Therapeutics, Inc. is incorporated in Nevada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding Hoth Therapeutics, Inc. (HOTH).